MedTrace Logo

Calypso Knee System Clinical Sub-study, OUS Continued Evaluation

NCT04548882 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-11-08

No results posted yet for this study

Summary

Calypso Knee System Clinical Study, OUS for subjects with symptomatic osteoarthritis of the medial compartment of the knee. The sub-study will achieve continued evaluation of the safety and clinical effectiveness of the Calypso Knee System.

Conditions

  • Osteoarthritis, Knee

Interventions

DEVICE

Calypso Knee System

The Calypso Knee System is an extra-capsular knee implant designed to fill the therapeutic gap between conservative care and more invasive surgical interventions for knee osteoarthritis.

Sponsors & Collaborators

  • Moximed

    lead INDUSTRY

Principal Investigators

  • Alexandra Kraenzlin · Moximed

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-11
Primary Completion
2021-10-12
Completion
2021-10-12
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04548882 on ClinicalTrials.gov